Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Asset Utilization Ratio (2016 - 2025)

Arcadia Biosciences filings provide 11 years of Asset Utilization Ratio readings, the most recent being 0.64 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 82.99% to 0.64 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.64, a 82.99% increase, with the full-year FY2025 number at 0.48, up 59.45% from a year prior.
  • Asset Utilization Ratio hit 0.64 in Q4 2025 for Arcadia Biosciences, up from 0.63 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 20.48 in Q1 2022 to a low of 0.08 in Q3 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.36 (2022), compared with a mean of 3.31.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 35218.52% in 2021 and later tumbled 121.19% in 2023.
  • Arcadia Biosciences' Asset Utilization Ratio stood at 16.37 in 2021, then crashed by 99.45% to 0.09 in 2022, then soared by 138.4% to 0.21 in 2023, then surged by 64.53% to 0.35 in 2024, then surged by 82.99% to 0.64 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.64 (Q4 2025), 0.63 (Q3 2025), and 0.52 (Q2 2025) per Business Quant data.